Eli Lilly and Co
SWB:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
|
B
|
Black Mammoth Metals Corp
OTC:LQRCF
|
CA |
|
A
|
Advantest Corp
XMUN:VAN
|
JP |
|
China Southern Airlines Co Ltd
OTC:CHKIF
|
CN |
|
California Resources Corp
NYSE:CRC
|
US |
|
Sega Sammy Holdings Inc
OTC:SGAMY
|
JP |
|
P
|
Perdoceo Education Corp
XMUN:CE1
|
US |
|
One Career Inc
TSE:4377
|
JP |
|
B
|
Bechtle AG
SWB:BC8
|
DE |
|
St James's Place PLC
LSE:STJ
|
UK |
|
E
|
Edenred SE
XMUN:QSV
|
FR |
|
KDX Realty Investment Corp
OTC:KDXRF
|
JP |
|
Upexi Inc
NASDAQ:UPXI
|
US |
|
Industrivarden AB
OTC:IDTVF
|
SE |
|
B
|
BYD Co Ltd
SWB:BY6
|
CN |
|
Austevoll Seafood ASA
OTC:ASTVF
|
NO |
|
N
|
Nippon Shokubai Co Ltd
OTC:NSHKF
|
JP |
|
ACS Actividades de Construccion y Servicios SA
F:OCI1
|
ES |
|
W
|
Williams Companies Inc
SWB:WMB
|
US |
|
E
|
Exxon Mobil Corp
BMV:XOM
|
US |
|
Cheniere Energy Partners LP
NYSE:CQP
|
US |
Bankruptcy Probability
Eli Lilly and Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eli Lilly and Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
652.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
505.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
378.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
347.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
197.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
167.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eli Lilly and Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eli Lilly and Co has total debt of 53.1B USD. This includes both short-term (5.3B USD) and long-term (47.9B USD) debt.
You can find a full breakdown on its Balance Sheet.